Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Light Sciences Oncology - making light-activated drug therapy a commercial reality

This article was originally published in Scrip

Executive Summary

As Dr Keltner pulled out what looked like a computer mouse from his briefcase, I was surprised to hear him say it was in fact Litx, the company's innovative light-activated drug technology. It didn't look like an innovative light-activated drug treatment for solid tumours, as LSO describes it. And it looked more like a device than a drug. So what was its relevance to the pharmaceutical industry?

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC000708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel